Last edition
News about Global Pharma
The trial's efficacy endpoints further underscore the superiority of Lutathera, with a progression-free survival hazard ratio of 0.28 and a median progression-free survival of 22.8 months, significantly outperforming high-dose octreotide LAR.
Global Pharma | 29/01/2024 | By Manvi | 614
Daewoong Pharmaceutical's Bersiporocin Receives 'Orphan Drug Designation' in Europe
This first-in-class PRS inhibitor has recently received 'Orphan Drug Designation (ODD)' from the European Medicines Agency (EMA), adding to its earlier designation by the US FDA for both IPF and systemic sclerosis.
Global Pharma | 29/01/2024 | By Manvi | 449
Esaote Unveils Two New Ultrasound Systems at Arab Health: MyLabA50 and MyLabA70
MyLab™A50 and MyLab™A70 embody the concept of Agility and are engineered to perform seamlessly in diverse clinical settings. With compact footprint, battery-operated lightweight and mobile design they meet the demands of most healthcare professionals.
Global Pharma | 29/01/2024 | By Manvi | 519
Glenmark Specialty S.A. (GSSA), a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) announced the signing of a license agreement with JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD (Jiangsu Alphamab) and 3D MEDICINES INC. (3D Medicines), (together as the Licensors), for KN035 (Envafolimab) for India, Asia Pacific.
Global Pharma | 25/01/2024 | By Manvi | 714
MolecuLight Wins VA Contract for Advanced Wound Imaging Devices
This contract, facilitated through the VA FSS program, reinforces MolecuLight's commitment to addressing healthcare requirements for Veterans and other federal government agencies.
Global Pharma | 25/01/2024 | By Manvi | 245
SHL Medical, SteriPack Group Forms Partnership for Drug Delivery System Assembly Services
The collaboration aims to establish a pre-validated final assembly service at the SteriPack facility in Poland, offering enhanced flexibility in supply chain strategies for their customers.
Global Pharma | 24/01/2024 | By Manvi | 746
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
Seegene Inc. announced its selection of Microsoft as a technology partner for its SG OneSystemTM business in London, UK to realize 'a world free from all diseases.'
Global Pharma | 24/01/2024 | By Manvi | 503
Heron Therapeutics' ZYNRELEF Receives FDA Approval for Expanded Surgical Indication
The expanded indication covers soft tissue and orthopedic surgical procedures, including foot and ankle, and others avoiding direct exposure to articular cartilage.
Global Pharma | 24/01/2024 | By Manvi | 953
Amadix's PreveCol Colorectal Cancer Screening Test Granted FDA Breakthrough Device Designation
This recognition positions Amadix as the first European company to achieve such status for early detection of colorectal cancer.
Global Pharma | 23/01/2024 | By Manvi | 714
Pharma Logistics Appoints David A. Hargraves as CEO
In response to the transition, Zaccaro expressed confidence in Hargraves' ability to lead Pharma Logistics into a future marked by growth and innovation.
Global Pharma | 23/01/2024 | By Manvi | 501
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy